McKone E - Search Results

1

A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis.

Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, Corvol H, Cheng SY, Elbert A, Faro A, Goss CH, Gulmans V, Marshall BC, McKone E, Middleton PG, Ruseckaite R, Stephenson AL, Carr SB; Global Registry Harmonization Group. Cosgriff R, et al. Among authors: mckone e. J Cyst Fibros. 2020 May;19(3):355-358. doi: 10.1016/j.jcf.2020.04.012. Epub 2020 Apr 25. J Cyst Fibros. 2020. PMID: 32376098 Free PMC article.

2

Experience using centralized spirometry in the phase 2 randomized, placebo-controlled, double-blind trial of denufosol in patients with mild to moderate cystic fibrosis.

Goss CH, McKone EF, Mathews D, Kerr D, Wanger JS, Millard SP; Cystic Fibrosis Therapeutics Development Network. Goss CH, et al. Among authors: mckone ef. J Cyst Fibros. 2008 Mar;7(2):147-53. doi: 10.1016/j.jcf.2007.07.006. Epub 2007 Aug 28. J Cyst Fibros. 2008. PMID: 17728193 Free article. Clinical Trial.

3

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.

Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, Dřevínek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, Rodriguez S, Yen K, Ordoñez C, Elborn JS; VX08-770-102 Study Group. Ramsey BW, et al. Among authors: mckone ef. N Engl J Med. 2011 Nov 3;365(18):1663-72. doi: 10.1056/NEJMoa1105185. N Engl J Med. 2011. PMID: 22047557 Free PMC article. Clinical Trial.

4

Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del/R117H/IVS8-5T.

Carter S, Kelly S, Caples E, Grogan B, Doyle J, Gallagher CG, McKone EF. Carter S, et al. Among authors: mckone ef. J Cyst Fibros. 2015 Jul;14(4):e4-5. doi: 10.1016/j.jcf.2015.01.010. Epub 2015 Feb 16. J Cyst Fibros. 2015. PMID: 25698453 Free article.

5

Estimating Direct Cost of Cystic Fibrosis Care Using Irish Registry Healthcare Resource Utilisation Data, 2008-2012.

Jackson AD, Jackson AL, Fletcher G, Doyle G, Harrington M, Zhou S, Cullinane F, Gallagher C, McKone E. Jackson AD, et al. Among authors: mckone e. Pharmacoeconomics. 2017 Oct;35(10):1087-1101. doi: 10.1007/s40273-017-0530-4. Pharmacoeconomics. 2017. PMID: 28699086

6

Amikacin liposome inhalation suspension for chronic Pseudomonas aeruginosa infection in cystic fibrosis.

Bilton D, Pressler T, Fajac I, Clancy JP, Sands D, Minic P, Cipolli M, Galeva I, Solé A, Quittner AL, Liu K, McGinnis JP 2nd, Eagle G, Gupta R, Konstan MW; CLEAR-108 Study Group. Bilton D, et al. J Cyst Fibros. 2020 Mar;19(2):284-291. doi: 10.1016/j.jcf.2019.08.001. Epub 2019 Aug 23. J Cyst Fibros. 2020. PMID: 31451351 Free PMC article. Clinical Trial.

7

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis.

McClenaghan E, Cosgriff R, Brownlee K, Ahern S, Burgel PR, Byrnes CA, Colombo C, Corvol H, Cheng SY, Daneau G, Elbert A, Faro A, Goss CH, Gulmans V, Gutierrez H, de Monestrol I, Jung A, Justus LN, Kashirskaya N, Marshall BC, McKone E, Middleton PG, Mondejar-Lopez P, Pastor-Vivero MD, Padoan R, Rizvi S, Ruseckaite R, Salvatore M, Stephenson AL, Filho LVRDS, Melo J, Zampoli M, Carr SB; Global Registry Harmonization Group. McClenaghan E, et al. Among authors: mckone e. J Cyst Fibros. 2020 Nov;19(6):868-871. doi: 10.1016/j.jcf.2020.10.003. Epub 2020 Nov 4. J Cyst Fibros. 2020. PMID: 33183965 Free PMC article.

8

Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Pope CE, Vo AT, Hayden HS, Weiss EJ, Durfey S, McNamara S, Ratjen A, Grogan B, Carter S, Nay L, Parsek MR, Singh PK, McKone EF, Aitken ML, Rosenfeld MR, Hoffman LR. Pope CE, et al. Among authors: mckone ef. J Cyst Fibros. 2021 Sep;20(5):742-746. doi: 10.1016/j.jcf.2020.12.002. Epub 2020 Dec 31. J Cyst Fibros. 2021. PMID: 33390317 Free PMC article.

9

COVID-19 vaccine prioritisation for people with cystic fibrosis.

Carr SB, Cosgriff R, Harutyunyan S, Middleton PG, Ruseckaite R, Ahern S, Daneau G, Filho LVRFDS, Stephenson AL, Cheng SY, Melo J, Corvol H, Burgel PR, Nährlich L, McKone E, Colombo C, Salvatore M, Padoan R, Abdrakhmanov O, Gulmans V, Byrnes CA, Amelina E, Kondratyeva E, Zhekayte E, Kashirskaya N, Zampoli M, Pastor-Vivero MD, Mondejar-Lopez P, de Monestrol I, Jung A, McClenaghan E, Brownlee K, Rizvi S, Goss CH, Elbert A, Faro A, Gutierrez H, Marshall BC. Carr SB, et al. Among authors: mckone e. J Cyst Fibros. 2021 Jul;20(4):715-716. doi: 10.1016/j.jcf.2021.03.028. Epub 2021 Apr 15. J Cyst Fibros. 2021. PMID: 33941502 Free PMC article. No abstract available.

10

Triple Therapy for Cystic Fibrosis Phe508del-Gating and -Residual Function Genotypes.

Barry PJ, Mall MA, Álvarez A, Colombo C, de Winter-de Groot KM, Fajac I, McBennett KA, McKone EF, Ramsey BW, Sutharsan S, Taylor-Cousar JL, Tullis E, Ahluwalia N, Jun LS, Moskowitz SM, Prieto-Centurion V, Tian S, Waltz D, Xuan F, Zhang Y, Rowe SM, Polineni D; VX18-445-104 Study Group. Barry PJ, et al. Among authors: mckone ef. N Engl J Med. 2021 Aug 26;385(9):815-825. doi: 10.1056/NEJMoa2100665. N Engl J Med. 2021. PMID: 34437784 Free PMC article. Clinical Trial.

11

Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study.

Carr SB, McClenaghan E, Elbert A, Faro A, Cosgriff R, Abdrakhmanov O, Brownlee K, Burgel PR, Byrnes CA, Cheng SY, Colombo C, Corvol H, Daneau G, Goss CH, Gulmans V, Gutierrez H, Harutyunyan S, Helmick M, Jung A, Kashirskaya N, McKone E, Melo J, Middleton PG, Mondejar-Lopez P, de Monestrol I, Nährlich L, Padoan R, Parker M, Pastor-Vivero MD, Rizvi S, Ruseckaite R, Salvatore M, da Silva-Filho LVRF, Versmessen N, Zampoli M, Marshall BC, Stephenson AL; CF Registry Global Collaboration. Carr SB, et al. Among authors: mckone e. J Cyst Fibros. 2022 Jul;21(4):e221-e231. doi: 10.1016/j.jcf.2022.06.006. Epub 2022 Jun 13. J Cyst Fibros. 2022. PMID: 35753987 Free PMC article.

12

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.

Sawicki GS, Konstan MW, McKone EF, Moss RB, Lubarsky B, Suthoff E, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan WJ, Duncan ME, Yang Y. Sawicki GS, et al. Among authors: mckone ef. Pulm Ther. 2022 Dec;8(4):385-395. doi: 10.1007/s41030-022-00202-y. Epub 2022 Nov 1. Pulm Ther. 2022. PMID: 36319933 Free PMC article.

13

Investigating serum extracellular vesicles in Cystic Fibrosis.

Trappe A, Lakkappa N, Carter S, Dillon E, Wynne K, McKone E, McNally P, Coppinger JA. Trappe A, et al. Among authors: mckone e. J Cyst Fibros. 2023 Jul;22(4):674-679. doi: 10.1016/j.jcf.2023.02.005. Epub 2023 Feb 27. J Cyst Fibros. 2023. PMID: 36858853 Free article.

14

Position paper: Models of post-transplant care for individuals with cystic fibrosis.

McKone E, Ramos KJ, Chaparro C, Blatter J, Hachem R, Anstead M, Vlahos F, Thaxton A, Hempstead S, Daniels T, Murray M, Sole A, Vos R, Tallarico E, Faro A, Pilewski JM. McKone E, et al. J Cyst Fibros. 2023 May;22(3):374-380. doi: 10.1016/j.jcf.2023.02.011. Epub 2023 Mar 5. J Cyst Fibros. 2023. PMID: 36882349 Free article.

15

Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective.

Mayer-Hamblett N, Clancy JP, Jain R, Donaldson SH, Fajac I, Goss CH, Polineni D, Ratjen F, Quon BS, Zemanick ET, Bell SC, Davies JC, Jain M, Konstan MW, Kerper NR, LaRosa T, Mall MA, McKone E, Pearson K, Pilewski JM, Quittell L, Rayment JH, Rowe SM, Taylor-Cousar JL, Retsch-Bogart G, Downey DG. Mayer-Hamblett N, et al. Among authors: mckone e. Lancet Respir Med. 2023 Oct;11(10):932-944. doi: 10.1016/S2213-2600(23)00297-7. Epub 2023 Sep 9. Lancet Respir Med. 2023. PMID: 37699421 Review.

16

Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues.

Burgel PR, Southern KW, Addy C, Battezzati A, Berry C, Bouchara JP, Brokaar E, Brown W, Azevedo P, Durieu I, Ekkelenkamp M, Finlayson F, Forton J, Gardecki J, Hodkova P, Hong G, Lowdon J, Madge S, Martin C, McKone E, Munck A, Ooi CY, Perrem L, Piper A, Prayle A, Ratjen F, Rosenfeld M, Sanders DB, Schwarz C, Taccetti G, Wainwright C, West NE, Wilschanski M, Bevan A, Castellani C, Drevinek P, Gartner S, Gramegna A, Lammertyn E, Landau EEC, Plant BJ, Smyth AR, van Koningsbruggen-Rietschel S, Middleton PG. Burgel PR, et al. Among authors: mckone e. J Cyst Fibros. 2024 Jan 16:S1569-1993(24)00005-5. doi: 10.1016/j.jcf.2024.01.005. Online ahead of print. J Cyst Fibros. 2024. PMID: 38233247 Free article.

17

Reproducibility of maximal exercise ergometer testing in patients with cystic fibrosis.

McKone EF, Barry SC, FitzGerald MX, Gallagher CG. McKone EF, et al. Chest. 1999 Aug;116(2):363-8. doi: 10.1378/chest.116.2.363. Chest. 1999. PMID: 10453863

18

The role of supplemental oxygen during submaximal exercise in patients with cystic fibrosis.

McKone EF, Barry SC, FitzGerald MX, Gallagher CG. McKone EF, et al. Eur Respir J. 2002 Jul;20(1):134-42. doi: 10.1183/09031936.02.00492001. Eur Respir J. 2002. PMID: 12166561 Free article.

19

High-resolution CT of nontuberculous mycobacterium infection in adult CF patients: diagnostic accuracy.

McEvoy S, Lavelle L, Kilcoyne A, McCarthy C, deJong PA, Loeve M, Tiddens HA, McKone E, Gallagher CG, Dodd JD. McEvoy S, et al. Among authors: mckone e. Eur Radiol. 2012 Dec;22(12):2736-42. doi: 10.1007/s00330-012-2558-3. Epub 2012 Jul 20. Eur Radiol. 2012. PMID: 22814825

20

Corrigendum to "WS04.1 The effect of Orkambi® on exercise capacity and muscle strength" [J Cyst Fibros, volume 16, supplement 1, June 2017, pages S6-S7].

Buckley R, Reilly CM, Kelly S, Ward E, O'Connor C, Carter S, Gallagher CG, McKone EF. Buckley R, et al. Among authors: mckone ef. J Cyst Fibros. 2017 Aug 18:S1569-1993(17)30771-3. doi: 10.1016/j.jcf.2017.06.003. Online ahead of print. J Cyst Fibros. 2017. PMID: 28826587 Free article. No abstract available.

21

Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.

Mainz JG, Lester K, Elnazir B, Williamson M, McKone E, Cox D, Linnane B, Zagoya C, Duckstein F, Barucha A, Davies JC, McNally P; RECOVER Study Group. Mainz JG, et al. Among authors: mckone e. J Cyst Fibros. 2023 Oct 7:S1569-1993(23)00922-0. doi: 10.1016/j.jcf.2023.10.001. Online ahead of print. J Cyst Fibros. 2023. PMID: 37806792

22

Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.

Adamali H, Armstrong ME, McLaughlin AM, Cooke G, McKone E, Costello CM, Gallagher CG, Leng L, Baugh JA, Fingerle-Rowson G, Bucala RJ, McLoughlin P, Donnelly SC. Adamali H, et al. Among authors: mckone e. Am J Respir Crit Care Med. 2012 Jul 15;186(2):162-9. doi: 10.1164/rccm.201110-1864OC. Epub 2012 May 16. Am J Respir Crit Care Med. 2012. PMID: 22592805 Free PMC article.

23

Recall of provision of sun protection measures to patients with cystic fibrosis being prescribed voriconazole.

Cunningham L, Moran M, Keating C, McKone E, Gallagher C, Lally A. Cunningham L, et al. Among authors: mckone e. Photodermatol Photoimmunol Photomed. 2015 Nov;31(6):341-2. doi: 10.1111/phpp.12189. Epub 2015 Jul 23. Photodermatol Photoimmunol Photomed. 2015. PMID: 26139441 No abstract available.

24

Chest CT abnormalities and quality of life: relationship in adult cystic fibrosis.

Kilcoyne A, Lavelle LP, McCarthy CJ, McEvoy SH, Fleming H, Gallagher A, Loeve M, Tiddens H, McKone E, Gallagher CC, Dodd JD. Kilcoyne A, et al. Among authors: mckone e. Ann Transl Med. 2016 Mar;4(5):87. doi: 10.21037/atm.2016.03.08. Ann Transl Med. 2016. PMID: 27047946 Free PMC article.

25

Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.

Uluer AZ, MacGregor G, Azevedo P, Indihar V, Keating C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Rubenstein RC, Taylor-Cousar JL, Tullis E, Yonker LM, Chu C, Lam AP, Nair N, Sosnay PR, Tian S, Van Goor F, Viswanathan L, Waltz D, Wang LT, Xi Y, Billings J, Horsley A; VX18-121-101; VX18-561-101 Study Groups. Uluer AZ, et al. Among authors: mckone ef. Lancet Respir Med. 2023 Jun;11(6):550-562. doi: 10.1016/S2213-2600(22)00504-5. Epub 2023 Feb 23. Lancet Respir Med. 2023. PMID: 36842446 Free article. Clinical Trial.

26

Socioeconomic disparities in European cystic fibrosis outcomes: time to close the gap.

McKone EF. McKone EF. Eur Respir J. 2024 Mar 7;63(3):2400328. doi: 10.1183/13993003.00328-2024. Print 2024 Mar. Eur Respir J. 2024. PMID: 38453247 No abstract available.

27

Repeatability of transient elastography in children.

Rowland M, McGee A, Broderick A, Drumm B, Connolly L, Daly LE, Drummond J, Fitzpatrick E, Linnane B, McCormick PA, McNally P, Rainford L, Bourke B; Cystic Fibrosis Registry of Ireland; Cystic Fibrosis Liver Disease Research Group. Rowland M, et al. Pediatr Res. 2020 Oct;88(4):587-592. doi: 10.1038/s41390-020-0916-4. Epub 2020 May 1. Pediatr Res. 2020. PMID: 32357363

28

Lemierre's syndrome.

O'Dwyer DN, Ryan S, O'Keefe T, Lyons J, Lavelle L, McKone E. O'Dwyer DN, et al. Among authors: mckone e. Ir J Med Sci. 2011 Jun;180(2):565-7. doi: 10.1007/s11845-008-0255-7. Epub 2008 Nov 11. Ir J Med Sci. 2011. PMID: 19002548

29

Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI.

Fleming H, Clifford SM, Haughey A, MacDermott R, McVeigh N, Healy GM, Lavelle L, Abbara S, Murphy DJ, Fabre A, McKone E, McCarthy C, Butler M, Doran P, Lynch DA, Keane MP, Dodd JD. Fleming H, et al. Among authors: mckone e. Eur Radiol Exp. 2020 Nov 3;4(1):61. doi: 10.1186/s41747-020-00187-w. Eur Radiol Exp. 2020. PMID: 33141269 Free PMC article.

30

Obliterating Airway Bronchus Sign of Occult Malignancy in Sarcoid Conglomerate Fibrotic Masses.

McVeigh N, Murphy DJ, McKone E, Dodd JD. McVeigh N, et al. Among authors: mckone e. J Clin Imaging Sci. 2021 Feb 25;11:12. doi: 10.25259/JCIS_103_2020. eCollection 2021. J Clin Imaging Sci. 2021. PMID: 33767904 Free PMC article.

31

EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity.

Darrah R, McKone E, O'Connor C, Rodgers C, Genatossio A, McNamara S, Gibson R, Stuart Elborn J, Ennis M, Gallagher CG, Kalsheker N, Aitken M, Wiese D, Dunn J, Smith P, Pace R, Londono D, Goddard KA, Knowles MR, Drumm ML. Darrah R, et al. Among authors: mckone e. Physiol Genomics. 2010 Mar 3;41(1):71-7. doi: 10.1152/physiolgenomics.00185.2009. Epub 2009 Dec 22. Physiol Genomics. 2010. PMID: 20028935 Free PMC article.

32

Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from a 192-week open-label extension study.

Daines CL, Tullis E, Costa S, Linnemann RW, Mall MA, McKone EF, Polineni D, Quon BS, Ringshausen FC, Rowe SM, Selvadurai H, Taylor-Cousar JL, Withers NJ, Ahluwalia N, Moskowitz SM, Prieto-Centurion V, Tan YV, Tian S, Weinstock T, Xuan F, Zhang Y, Ramsey B, Griese M; VX17-445-105 Study Group. Daines CL, et al. Among authors: mckone ef. Eur Respir J. 2023 Dec 7;62(6):2202029. doi: 10.1183/13993003.02029-2022. Print 2023 Dec. Eur Respir J. 2023. PMID: 37945033 Free PMC article. Clinical Trial.

33

Application of Advanced Imaging to Prostate Cancer Diagnosis and Management: A Narrative Review of Current Practice and Unanswered Questions.

McKone EL, Sutton EA, Johnson GB, Phillips RM. McKone EL, et al. J Clin Med. 2024 Jan 13;13(2):446. doi: 10.3390/jcm13020446. J Clin Med. 2024. PMID: 38256579 Free PMC article. Review.

34

Elexacaftor/Tezacaftor/Ivacaftor Treatment and Depression-related Events.

Ramsey B, Correll CU, DeMaso DR, McKone E, Tullis E, Taylor-Cousar JL, Chu C, Volkova N, Ahluwalia N, Waltz D, Tian S, Mall MA. Ramsey B, et al. Among authors: mckone e. Am J Respir Crit Care Med. 2024 Feb 1;209(3):299-306. doi: 10.1164/rccm.202308-1525OC. Am J Respir Crit Care Med. 2024. PMID: 37890129 Free PMC article. Review.

35

Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.

McNally P, Lester K, Stone G, Elnazir B, Williamson M, Cox D, Linnane B, Kirwan L, Rea D, O'Regan P, Semple T, Saunders C, Tiddens HAWM, McKone E, Davies JC; RECOVER Study Group. McNally P, et al. Among authors: mckone e. Am J Respir Crit Care Med. 2023 Nov 1;208(9):917-929. doi: 10.1164/rccm.202308-1317OC. Am J Respir Crit Care Med. 2023. PMID: 37703083 Clinical Trial.

36

The composite effect reveals that human (but not other primate) faces are special to humans.

Sulikowski D, Favelle S, McKone E, Willis M, Burke D. Sulikowski D, et al. Among authors: mckone e. PLoS One. 2023 May 30;18(5):e0286451. doi: 10.1371/journal.pone.0286451. eCollection 2023. PLoS One. 2023. PMID: 37252925 Free PMC article.

37

64-Year-Old Female With Right Upper Quadrant Pain and Jaundice.

McKone EL, Liddell SS, Oxentenko AS. McKone EL, et al. Mayo Clin Proc. 2023 Jun;98(6):927-932. doi: 10.1016/j.mayocp.2022.10.008. Epub 2023 Apr 29. Mayo Clin Proc. 2023. PMID: 37125975 No abstract available.

38

Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2-5 Years with Cystic Fibrosis and at Least One F508del Allele.

Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, Niu T, Weinstock T, Ratjen F, Rosenfeld M. Goralski JL, et al. Among authors: mckone e. Am J Respir Crit Care Med. 2023 Jul 1;208(1):59-67. doi: 10.1164/rccm.202301-0084OC. Am J Respir Crit Care Med. 2023. PMID: 36921081 Free PMC article.

39

Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.

Carter SC, Franciosi AN, O'Shea KM, O'Carroll OM, Sharma A, Bell A, Keogan B, O'Reilly P, Coughlan S, Law SM, Gray RD, Hisert KB, Singh PK, Cooke G, Grogan B, De Gascun CF, Gallagher CG, Nicholson TT, Quon BS, McKone EF. Carter SC, et al. Ann Am Thorac Soc. 2022 Nov;19(11):1818-1826. doi: 10.1513/AnnalsATS.202111-1266OC. Ann Am Thorac Soc. 2022. PMID: 35713619 Free PMC article.

40

Priority areas in the assessment and treatment of CF exacerbations: Location, duration, inflammation.

Carter SC, McKone EF. Carter SC, et al. J Cyst Fibros. 2022 Jul;21(4):556-557. doi: 10.1016/j.jcf.2022.04.012. Epub 2022 Apr 28. J Cyst Fibros. 2022. PMID: 35491318 No abstract available.

41

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.

Jung A, Orenti A, Dunlevy F, Aleksejeva E, Bakkeheim E, Bobrovnichy V, Carr SB, Colombo C, Corvol H, Cosgriff R, Daneau G, Dogru D, Drevinek P, Vukic AD, Fajac I, Fox A, Fustik S, Gulmans V, Harutyunyan S, Hatziagorou E, Kasmi I, Kayserová H, Kondratyeva E, Krivec U, Makukh H, Malakauskas K, McKone EF, Mei-Zahav M, de Monestrol I, Olesen HV, Padoan R, Parulava T, Pastor-Vivero MD, Pereira L, Petrova G, Pfleger A, Pop L, van Rens JG, Rodic M, Schlesser M, Storms V, Turcu O, Woz Niacki L, Yiallouros P, Zolin A, Downey DG, Naehrlich L. Jung A, et al. Among authors: mckone ef. ERJ Open Res. 2021 Dec 27;7(4):00411-2021. doi: 10.1183/23120541.00411-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34984210 Free PMC article.

42

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.

Sutharsan S, McKone EF, Downey DG, Duckers J, MacGregor G, Tullis E, Van Braeckel E, Wainwright CE, Watson D, Ahluwalia N, Bruinsma BG, Harris C, Lam AP, Lou Y, Moskowitz SM, Tian S, Yuan J, Waltz D, Mall MA; VX18-445-109 study group. Sutharsan S, et al. Among authors: mckone ef. Lancet Respir Med. 2022 Mar;10(3):267-277. doi: 10.1016/S2213-2600(21)00454-9. Epub 2021 Dec 20. Lancet Respir Med. 2022. PMID: 34942085 Clinical Trial.

43

A population-level strain genotyping method to study pathogen strain dynamics in human infections.

Morgan SJ, Durfey SL, Ravishankar S, Jorth P, Ni W, Skerrett DT, Aitken ML, McKone EF, Salipante SJ, Radey MC, Singh PK. Morgan SJ, et al. JCI Insight. 2021 Dec 22;6(24):e152472. doi: 10.1172/jci.insight.152472. JCI Insight. 2021. PMID: 34935640 Free PMC article.

44

Combining Ivacaftor and Intensive Antibiotics Achieves Limited Clearance of Cystic Fibrosis Infections.

Durfey SL, Pipavath S, Li A, Vo AT, Ratjen A, Carter S, Morgan SJ, Radey MC, Grogan B, Salipante SJ, Welsh MJ, Stoltz DA, Goss CH, McKone EF, Singh PK. Durfey SL, et al. mBio. 2021 Dec 21;12(6):e0314821. doi: 10.1128/mbio.03148-21. Epub 2021 Dec 14. mBio. 2021. PMID: 34903059 Free PMC article. Clinical Trial.

45

Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review.

Nicholson TT, Smith A, McKone EF, Gallagher CG. Nicholson TT, et al. J Cyst Fibros. 2022 Jul;21(4):562-573. doi: 10.1016/j.jcf.2021.08.017. Epub 2021 Sep 27. J Cyst Fibros. 2022. PMID: 34588142

46

Relationships between retinal structure and function and vision-related quality of life measures in advanced age-related macular degeneration.

Sabeti F, Lane J, Rohan EMF, Essex RW, McKone E, Maddess T. Sabeti F, et al. Among authors: mckone e. Graefes Arch Clin Exp Ophthalmol. 2021 Dec;259(12):3687-3696. doi: 10.1007/s00417-021-05296-9. Epub 2021 Jul 8. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 34236475

47

Inflammatory cytokines TNF-α and IL-17 enhance the efficacy of cystic fibrosis transmembrane conductance regulator modulators.

Rehman T, Karp PH, Tan P, Goodell BJ, Pezzulo AA, Thurman AL, Thornell IM, Durfey SL, Duffey ME, Stoltz DA, McKone EF, Singh PK, Welsh MJ. Rehman T, et al. Among authors: mckone ef. J Clin Invest. 2021 Aug 16;131(16):e150398. doi: 10.1172/JCI150398. J Clin Invest. 2021. PMID: 34166230 Free PMC article.

48

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.

Naehrlich L, Orenti A, Dunlevy F, Kasmi I, Harutyunyan S, Pfleger A, Keegan S, Daneau G, Petrova G, Tješić-Drinković D, Yiallouros P, Bilkova A, Olesen HV, Burgel PR, Parulava T, Diamantea F, Párniczky A, McKone EF, Mei-Zahav M, Salvatore M, Colombo C, Aleksejeva E, Malakauskas K, Schlesser M, Fustik S, Turcu O, Zomer-van Ommen D, Wathne AS, Woźniacki Ł, Pereira L, Pop L, Kashirskaya N, Rodić M, Kayserova H, Krivecs U, Mondejar-Lopez P, de Monestrol I, Dogru D, Makukh H, Cosgriff R, van Koningsbruggen-Rietschel S, Jung A; European Cystic Fibrosis COVID project group. Naehrlich L, et al. Among authors: mckone ef. J Cyst Fibros. 2021 Jul;20(4):566-577. doi: 10.1016/j.jcf.2021.03.017. Epub 2021 Apr 18. J Cyst Fibros. 2021. PMID: 34016559 Free PMC article.

49

Why the other-race effect matters: Poor recognition of other-race faces impacts everyday social interactions.

McKone E, Dawel A, Robbins RA, Shou Y, Chen N, Crookes K. McKone E, et al. Br J Psychol. 2023 May;114 Suppl 1:230-252. doi: 10.1111/bjop.12508. Epub 2021 May 19. Br J Psychol. 2023. PMID: 34010458

50

Correlation of Central Versus Peripheral Macular Structure-Function With Acuity in Age-Related Macular Degeneration.

Sabeti F, Lane J, Rohan EMF, Rai BB, Essex RW, McKone E, Maddess T. Sabeti F, et al. Among authors: mckone e. Transl Vis Sci Technol. 2021 Feb 5;10(2):10. doi: 10.1167/tvst.10.2.10. Transl Vis Sci Technol. 2021. PMID: 34003894 Free PMC article.

51

A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele.

Zemanick ET, Taylor-Cousar JL, Davies J, Gibson RL, Mall MA, McKone EF, McNally P, Ramsey BW, Rayment JH, Rowe SM, Tullis E, Ahluwalia N, Chu C, Ho T, Moskowitz SM, Noel S, Tian S, Waltz D, Weinstock TG, Xuan F, Wainwright CE, McColley SA. Zemanick ET, et al. Among authors: mckone ef. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1522-1532. doi: 10.1164/rccm.202102-0509OC. Am J Respir Crit Care Med. 2021. PMID: 33734030 Free PMC article. Clinical Trial.

52

Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study.

McKone EF, Ariti C, Jackson A, Zolin A, Carr SB, Orenti A, van Rens JG, Lemonnier L, Macek M Jr, Keogh RH, Naehrlich L; European Cystic Fibrosis Society Patient Registry; ECFSPR contributors list consists of the representatives of the countries whose data is used in this article, and the members of the Scientific Committee who reviewed the initial data application and the final manuscript. Collaborating authors:. McKone EF, et al. Eur Respir J. 2021 Oct 1;58(3):2002288. doi: 10.1183/13993003.02288-2020. Print 2021 Sep. Eur Respir J. 2021. PMID: 33678607 Free article.

53

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.

Flume PA, Biner RF, Downey DG, Brown C, Jain M, Fischer R, De Boeck K, Sawicki GS, Chang P, Paz-Diaz H, Rubin JL, Yang Y, Hu X, Pasta DJ, Millar SJ, Campbell D, Wang X, Ahluwalia N, Owen CA, Wainwright CE; VX14-661-110 study group. Flume PA, et al. Lancet Respir Med. 2021 Jul;9(7):733-746. doi: 10.1016/S2213-2600(20)30510-5. Epub 2021 Feb 10. Lancet Respir Med. 2021. PMID: 33581080

54

A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation.

McKone EF, DiMango EA, Sutharsan S, Barto TL, Campbell D, Ahluwalia N, Higgins M, Owen CA, Tullis E. McKone EF, et al. J Cyst Fibros. 2021 Mar;20(2):234-242. doi: 10.1016/j.jcf.2020.11.003. Epub 2020 Dec 16. J Cyst Fibros. 2021. PMID: 33339768 Free article. Clinical Trial.

55

CF pulmonary exacerbations-Steps in the right direction.

Carter SC, McKone EF. Carter SC, et al. J Cyst Fibros. 2021 Jan;20(1):3-4. doi: 10.1016/j.jcf.2020.11.001. Epub 2020 Nov 10. J Cyst Fibros. 2021. PMID: 33187934 Free article. No abstract available.

56

Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease.

O'Shea KM, O'Carroll OM, Carroll C, Grogan B, Connolly A, O'Shaughnessy L, Nicholson TT, Gallagher CG, McKone EF. O'Shea KM, et al. Eur Respir J. 2021 Feb 25;57(2):2003079. doi: 10.1183/13993003.03079-2020. Print 2021 Feb. Eur Respir J. 2021. PMID: 33154033 Free article. No abstract available.

57

CFTR Modulator Therapy Enhances Peripheral Blood Monocyte Contributions to Immune Responses in People With Cystic Fibrosis.

Hisert KB, Birkland TP, Schoenfelt KQ, Long ME, Grogan B, Carter S, Liles WC, McKone EF, Becker L, Manicone AM, Gharib SA. Hisert KB, et al. Among authors: mckone ef. Front Pharmacol. 2020 Aug 13;11:1219. doi: 10.3389/fphar.2020.01219. eCollection 2020. Front Pharmacol. 2020. PMID: 33013356 Free PMC article.

58

Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical Trial.

Griese M, Costa S, Linnemann RW, Mall MA, McKone EF, Polineni D, Quon BS, Ringshausen FC, Taylor-Cousar JL, Withers NJ, Moskowitz SM, Daines CL. Griese M, et al. Am J Respir Crit Care Med. 2021 Feb 1;203(3):381-385. doi: 10.1164/rccm.202008-3176LE. Am J Respir Crit Care Med. 2021. PMID: 32969708 Free PMC article. Clinical Trial. No abstract available.

59

Ivacaftor modifies cystic fibrosis neutrophil phenotype in subjects with R117H residual function CFTR mutations.

Hardisty GR, Law SM, Carter S, Grogan B, Singh PK, McKone EF, Gray RD. Hardisty GR, et al. Eur Respir J. 2021 Jan 21;57(1):2002161. doi: 10.1183/13993003.02161-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32855222 Free PMC article.

60

Dornase alfa and rate of lung function decline in European patients with cystic fibrosis: A retrospective registry cohort study.

McKone EF, Jackson AD, Fletcher G, Kirwan L. McKone EF, et al. J Cyst Fibros. 2021 May;20(3):552-554. doi: 10.1016/j.jcf.2020.08.004. Epub 2020 Aug 22. J Cyst Fibros. 2021. PMID: 32839093 Free article. No abstract available.

61

Tocilizumab therapy in individuals with COVID-19 infection and hyperinflammatory state.

McCarthy C, Savinelli S, Feeney ER, Butler MW, O'Broin C, Ryan S, O'Neill L, Murphy DJ, Gallagher CG, McKone EF, Waqas S, Cotter A, Doran P, Keane MP, Mallon PW. McCarthy C, et al. Respirology. 2020 Oct;25(10):1090-1094. doi: 10.1111/resp.13912. Epub 2020 Jul 21. Respirology. 2020. PMID: 32696570 Free PMC article. No abstract available.

62

Correlation between Ivacaftor-induced CFTR Activation in Airway Epithelial Cells and Improved Lung Function: A Proof-of-Concept Study.

Debley JS, Barrow KA, Rich LM, Singh P, McKone EF, Nichols DP. Debley JS, et al. Ann Am Thorac Soc. 2020 Aug;17(8):1024-1027. doi: 10.1513/AnnalsATS.202001-082RL. Ann Am Thorac Soc. 2020. PMID: 32421352 Free PMC article. No abstract available.

63

Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis.

Hisert KB, Birkland TP, Schoenfelt KQ, Long ME, Grogan B, Carter S, Liles WC, McKone EF, Becker L, Manicone AM. Hisert KB, et al. Among authors: mckone ef. ERJ Open Res. 2020 Apr 19;6(2):00318-2019. doi: 10.1183/23120541.00318-2019. eCollection 2020 Apr. ERJ Open Res. 2020. PMID: 32337217 Free PMC article.

64

Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis.

Useckaite Z, Ward MP, Trappe A, Reilly R, Lennon J, Davage H, Matallanas D, Cassidy H, Dillon ET, Brennan K, Doyle SL, Carter S, Donnelly S, Linnane B, McKone EF, McNally P, Coppinger JA. Useckaite Z, et al. Thorax. 2020 Jun;75(6):449-458. doi: 10.1136/thoraxjnl-2019-214027. Epub 2020 Apr 7. Thorax. 2020. PMID: 32265339 Free PMC article.

65

Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.

Middleton PG, Mall MA, Dřevínek P, Lands LC, McKone EF, Polineni D, Ramsey BW, Taylor-Cousar JL, Tullis E, Vermeulen F, Marigowda G, McKee CM, Moskowitz SM, Nair N, Savage J, Simard C, Tian S, Waltz D, Xuan F, Rowe SM, Jain R; VX17-445-102 Study Group. Middleton PG, et al. Among authors: mckone ef. N Engl J Med. 2019 Nov 7;381(19):1809-1819. doi: 10.1056/NEJMoa1908639. Epub 2019 Oct 31. N Engl J Med. 2019. PMID: 31697873 Free PMC article. Clinical Trial.

66

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial.

Heijerman HGM, McKone EF, Downey DG, Van Braeckel E, Rowe SM, Tullis E, Mall MA, Welter JJ, Ramsey BW, McKee CM, Marigowda G, Moskowitz SM, Waltz D, Sosnay PR, Simard C, Ahluwalia N, Xuan F, Zhang Y, Taylor-Cousar JL, McCoy KS; VX17-445-103 Trial Group. Heijerman HGM, et al. Among authors: mckone ef. Lancet. 2019 Nov 23;394(10212):1940-1948. doi: 10.1016/S0140-6736(19)32597-8. Epub 2019 Oct 31. Lancet. 2019. PMID: 31679946 Free PMC article. Clinical Trial.

67

The future of cystic fibrosis care: a global perspective.

Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, Fajac I, Goss CH, Drevinek P, Farrell PM, Gravelle AM, Havermans T, Mayer-Hamblett N, Kashirskaya N, Kerem E, Mathew JL, McKone EF, Naehrlich L, Nasr SZ, Oates GR, O'Neill C, Pypops U, Raraigh KS, Rowe SM, Southern KW, Sivam S, Stephenson AL, Zampoli M, Ratjen F. Bell SC, et al. Among authors: mckone ef. Lancet Respir Med. 2020 Jan;8(1):65-124. doi: 10.1016/S2213-2600(19)30337-6. Epub 2019 Sep 27. Lancet Respir Med. 2020. PMID: 31570318 Free PMC article. Review.

68

A critical period for faces: Other-race face recognition is improved by childhood but not adult social contact.

McKone E, Wan L, Pidcock M, Crookes K, Reynolds K, Dawel A, Kidd E, Fiorentini C. McKone E, et al. Sci Rep. 2019 Sep 6;9(1):12820. doi: 10.1038/s41598-019-49202-0. Sci Rep. 2019. PMID: 31492907 Free PMC article.

69

Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles.

Taylor-Cousar JL, Mall MA, Ramsey BW, McKone EF, Tullis E, Marigowda G, McKee CM, Waltz D, Moskowitz SM, Savage J, Xuan F, Rowe SM. Taylor-Cousar JL, et al. Among authors: mckone ef. ERJ Open Res. 2019 Jun 17;5(2):00082-2019. doi: 10.1183/23120541.00082-2019. eCollection 2019 Apr. ERJ Open Res. 2019. PMID: 31218221 Free PMC article.

70

Caricaturing can improve facial expression recognition in low-resolution images and age-related macular degeneration.

Lane J, Robbins RA, Rohan EMF, Crookes K, Essex RW, Maddess T, Sabeti F, Mazlin JL, Irons J, Gradden T, Dawel A, Barnes N, He X, Smithson M, McKone E. Lane J, et al. Among authors: mckone e. J Vis. 2019 Jun 3;19(6):18. doi: 10.1167/19.6.18. J Vis. 2019. PMID: 31215978 Free article.

71

GLPG1837, a CFTR potentiator, in p.Gly551Asp (G551D)-CF patients: An open-label, single-arm, phase 2a study (SAPHIRA1).

Davies JC, Van de Steen O, van Koningsbruggen-Rietschel S, Drevinek P, Derichs N, McKone EF, Kanters D, Allamassey L, Namour F, de Kock H, Conrath K. Davies JC, et al. J Cyst Fibros. 2019 Sep;18(5):693-699. doi: 10.1016/j.jcf.2019.05.006. Epub 2019 May 27. J Cyst Fibros. 2019. PMID: 31147302 Free article. Clinical Trial.

72

Pathway analysis of a genome-wide gene by air pollution interaction study in asthmatic children.

Ierodiakonou D, Coull BA, Zanobetti A, Postma DS, Boezen HM, Vonk JM, McKone EF, Schildcrout JS, Koppelman GH, Croteau-Chonka DC, Lumley T, Koutrakis P, Schwartz J, Gold DR, Weiss ST. Ierodiakonou D, et al. J Expo Sci Environ Epidemiol. 2019 Jun;29(4):539-547. doi: 10.1038/s41370-019-0136-3. Epub 2019 Apr 26. J Expo Sci Environ Epidemiol. 2019. PMID: 31028280 Free PMC article.

73

Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines.

Ramos KJ, Smith PJ, McKone EF, Pilewski JM, Lucy A, Hempstead SE, Tallarico E, Faro A, Rosenbluth DB, Gray AL, Dunitz JM; CF Lung Transplant Referral Guidelines Committee. Ramos KJ, et al. Among authors: mckone ef. J Cyst Fibros. 2019 May;18(3):321-333. doi: 10.1016/j.jcf.2019.03.002. Epub 2019 Mar 27. J Cyst Fibros. 2019. PMID: 30926322 Free PMC article. Review.

74

Impacts of impaired face perception on social interactions and quality of life in age-related macular degeneration: A qualitative study and new community resources.

Lane J, Rohan EMF, Sabeti F, Essex RW, Maddess T, Dawel A, Robbins RA, Barnes N, He X, McKone E. Lane J, et al. Among authors: mckone e. PLoS One. 2018 Dec 31;13(12):e0209218. doi: 10.1371/journal.pone.0209218. eCollection 2018. PLoS One. 2018. PMID: 30596660 Free PMC article.

75

Reduced willingness to approach genuine smilers in social anxiety explained by potential for social evaluation, not misperception of smile authenticity.

Dawel A, Dumbleton R, O'Kearney R, Wright L, McKone E. Dawel A, et al. Among authors: mckone e. Cogn Emot. 2019 Nov;33(7):1342-1355. doi: 10.1080/02699931.2018.1561421. Epub 2018 Dec 26. Cogn Emot. 2019. PMID: 30585120

76

Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland.

Kirwan L, Fletcher G, Harrington M, Jeleniewska P, Zhou S, Casserly B, Gallagher CG, Greally P, Gunaratnam C, Herzig M, Linnane B, McElvaney NG, McKone EF, McNally P, Mullane D, Ní Chróinín M, O'Mahony M, Plant BJ, Jackson AD. Kirwan L, et al. Ann Am Thorac Soc. 2019 Feb;16(2):209-216. doi: 10.1513/AnnalsATS.201802-149OC. Ann Am Thorac Soc. 2019. PMID: 30427731

77

VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Davies JC, Moskowitz SM, Brown C, Horsley A, Mall MA, McKone EF, Plant BJ, Prais D, Ramsey BW, Taylor-Cousar JL, Tullis E, Uluer A, McKee CM, Robertson S, Shilling RA, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Rowe SM; VX16-659-101 Study Group. Davies JC, et al. Among authors: mckone ef. N Engl J Med. 2018 Oct 25;379(17):1599-1611. doi: 10.1056/NEJMoa1807119. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334693 Free PMC article. Clinical Trial.

78

VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles.

Keating D, Marigowda G, Burr L, Daines C, Mall MA, McKone EF, Ramsey BW, Rowe SM, Sass LA, Tullis E, McKee CM, Moskowitz SM, Robertson S, Savage J, Simard C, Van Goor F, Waltz D, Xuan F, Young T, Taylor-Cousar JL; VX16-445-001 Study Group. Keating D, et al. Among authors: mckone ef. N Engl J Med. 2018 Oct 25;379(17):1612-1620. doi: 10.1056/NEJMoa1807120. Epub 2018 Oct 18. N Engl J Med. 2018. PMID: 30334692 Free PMC article. Clinical Trial.

79

Caricaturing as a general method to improve poor face recognition: Evidence from low-resolution images, other-race faces, and older adults.

Dawel A, Wong TY, McMorrow J, Ivanovici C, He X, Barnes N, Irons J, Gradden T, Robbins R, Goodhew SC, Lane J, McKone E. Dawel A, et al. Among authors: mckone e. J Exp Psychol Appl. 2019 Jun;25(2):256-279. doi: 10.1037/xap0000180. Epub 2018 Oct 15. J Exp Psychol Appl. 2019. PMID: 30321022

80

Improving face identity perception in age-related macular degeneration via caricaturing.

Lane J, Rohan EMF, Sabeti F, Essex RW, Maddess T, Barnes N, He X, Robbins RA, Gradden T, McKone E. Lane J, et al. Among authors: mckone e. Sci Rep. 2018 Oct 12;8(1):15205. doi: 10.1038/s41598-018-33543-3. Sci Rep. 2018. PMID: 30315188 Free PMC article.

81

Caricaturing faces to improve identity recognition in low vision simulations: How effective is current-generation automatic assignment of landmark points?

McKone E, Robbins RA, He X, Barnes N. McKone E, et al. PLoS One. 2018 Oct 4;13(10):e0204361. doi: 10.1371/journal.pone.0204361. eCollection 2018. PLoS One. 2018. PMID: 30286112 Free PMC article.

82

Ivacaftor-induced sweat chloride reductions correlate with increases in airway surface liquid pH in cystic fibrosis.

Abou Alaiwa MH, Launspach JL, Grogan B, Carter S, Zabner J, Stoltz DA, Singh PK, McKone EF, Welsh MJ. Abou Alaiwa MH, et al. JCI Insight. 2018 Aug 9;3(15):e121468. doi: 10.1172/jci.insight.121468. eCollection 2018 Aug 9. JCI Insight. 2018. PMID: 30089726 Free PMC article.

83

All tears are crocodile tears: Impaired perception of emotion authenticity in psychopathic traits.

Dawel A, Wright L, Dumbleton R, McKone E. Dawel A, et al. Among authors: mckone e. Personal Disord. 2019 Mar;10(2):185-197. doi: 10.1037/per0000301. Epub 2018 Jul 16. Personal Disord. 2019. PMID: 30010374

84

Lung function decline is delayed but not decreased in patients with cystic fibrosis and the R117H gene mutation.

Wagener JS, Millar SJ, Mayer-Hamblett N, Sawicki GS, McKone EF, Goss CH, Konstan MW, Morgan WJ, Pasta DJ, Moss RB. Wagener JS, et al. J Cyst Fibros. 2018 Jul;17(4):503-510. doi: 10.1016/j.jcf.2017.10.003. Epub 2017 Oct 31. J Cyst Fibros. 2018. PMID: 29100868 Free PMC article.

85

Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.

Taylor-Cousar JL, Munck A, McKone EF, van der Ent CK, Moeller A, Simard C, Wang LT, Ingenito EP, McKee C, Lu Y, Lekstrom-Himes J, Elborn JS. Taylor-Cousar JL, et al. N Engl J Med. 2017 Nov 23;377(21):2013-2023. doi: 10.1056/NEJMoa1709846. Epub 2017 Nov 3. N Engl J Med. 2017. PMID: 29099344 Free article. Clinical Trial.

86

Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis.

Gray RD, Hardisty G, Regan KH, Smith M, Robb CT, Duffin R, Mackellar A, Felton JM, Paemka L, McCullagh BN, Lucas CD, Dorward DA, McKone EF, Cooke G, Donnelly SC, Singh PK, Stoltz DA, Haslett C, McCray PB, Whyte MKB, Rossi AG, Davidson DJ. Gray RD, et al. Thorax. 2018 Feb;73(2):134-144. doi: 10.1136/thoraxjnl-2017-210134. Epub 2017 Sep 15. Thorax. 2018. PMID: 28916704 Free PMC article.

87

Diagnosing prosopagnosia in East Asian individuals: Norms for the Cambridge Face Memory Test-Chinese.

McKone E, Wan L, Robbins R, Crookes K, Liu J. McKone E, et al. Cogn Neuropsychol. 2017 Jul;34(5):253-268. doi: 10.1080/02643294.2017.1371682. Epub 2017 Sep 14. Cogn Neuropsychol. 2017. PMID: 28906173

88

Adaptive face coding contributes to individual differences in facial expression recognition independently of affective factors.

Palermo R, Jeffery L, Lewandowsky J, Fiorentini C, Irons JL, Dawel A, Burton N, McKone E, Rhodes G. Palermo R, et al. Among authors: mckone e. J Exp Psychol Hum Percept Perform. 2018 Apr;44(4):503-517. doi: 10.1037/xhp0000463. Epub 2017 Aug 21. J Exp Psychol Hum Percept Perform. 2018. PMID: 28825500 Free article.

89

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis.

Reilly R, Mroz MS, Dempsey E, Wynne K, Keely SJ, McKone EF, Hiebel C, Behl C, Coppinger JA. Reilly R, et al. Among authors: mckone ef. Sci Rep. 2017 Aug 9;7(1):7642. doi: 10.1038/s41598-017-06588-z. Sci Rep. 2017. PMID: 28794469 Free PMC article.

90

Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially contributing to cystic fibrosis pathogenesis.

Tynan A, Mawhinney L, Armstrong ME, O'Reilly C, Kennedy S, Caraher E, Jülicher K, O'Dwyer D, Maher L, Schaffer K, Fabre A, McKone EF, Leng L, Bucala R, Bernhagen J, Cooke G, Donnelly SC. Tynan A, et al. Among authors: mckone ef. FASEB J. 2017 Nov;31(11):5102-5110. doi: 10.1096/fj.201700463R. Epub 2017 Aug 2. FASEB J. 2017. PMID: 28768722 Free PMC article.

Our novel findings support the concept of an anti-MIF strategy that targets this enzymatic activity as a potential future antibacterial therapeutic approach.-Tynan, A., Mawhinney, L., Armstrong, M. E., O'Reilly, C., Kennedy, S., Caraher, E., Julicher, K., O'Dwyer, D …

Our novel findings support the concept of an anti-MIF strategy that targets this enzymatic activity as a potential future antibacterial ther …

91

Face identity recognition in simulated prosthetic vision is poorer than previously reported and can be improved by caricaturing.

Irons JL, Gradden T, Zhang A, He X, Barnes N, Scott AF, McKone E. Irons JL, et al. Among authors: mckone e. Vision Res. 2017 Aug;137:61-79. doi: 10.1016/j.visres.2017.06.002. Epub 2017 Jul 15. Vision Res. 2017. PMID: 28688907 Free article.

92

Patients with Cystic Fibrosis and a G551D or Homozygous F508del Mutation: Similar Lung Function Decline.

Sawicki GS, McKone EF, Millar SJ, Pasta DJ, Konstan MW, Lubarsky B, Wagener JS. Sawicki GS, et al. Am J Respir Crit Care Med. 2017 Jun 15;195(12):1673-1676. doi: 10.1164/rccm.201608-1678LE. Am J Respir Crit Care Med. 2017. PMID: 28617084 No abstract available.

93

A treatment evaluator tool to monitor the real-world effectiveness of inhaled aztreonam lysine in cystic fibrosis.

Plant BJ, Downey DG, Eustace JA, Gunaratnam C, Haworth CS, Jones AM, McKone EF, Peckham DG, Ketchell RI, Bilton D. Plant BJ, et al. J Cyst Fibros. 2017 Nov;16(6):695-701. doi: 10.1016/j.jcf.2017.02.006. Epub 2017 Apr 6. J Cyst Fibros. 2017. PMID: 28392014 Free article.

94

Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.

Hisert KB, Heltshe SL, Pope C, Jorth P, Wu X, Edwards RM, Radey M, Accurso FJ, Wolter DJ, Cooke G, Adam RJ, Carter S, Grogan B, Launspach JL, Donnelly SC, Gallagher CG, Bruce JE, Stoltz DA, Welsh MJ, Hoffman LR, McKone EF, Singh PK. Hisert KB, et al. Among authors: mckone ef. Am J Respir Crit Care Med. 2017 Jun 15;195(12):1617-1628. doi: 10.1164/rccm.201609-1954OC. Am J Respir Crit Care Med. 2017. PMID: 28222269 Free PMC article.

95

Assessment of safety and efficacy of long-term treatment with combination lumacaftor and ivacaftor therapy in patients with cystic fibrosis homozygous for the F508del-CFTR mutation (PROGRESS): a phase 3, extension study.

Konstan MW, McKone EF, Moss RB, Marigowda G, Tian S, Waltz D, Huang X, Lubarsky B, Rubin J, Millar SJ, Pasta DJ, Mayer-Hamblett N, Goss CH, Morgan W, Sawicki GS. Konstan MW, et al. Lancet Respir Med. 2017 Feb;5(2):107-118. doi: 10.1016/S2213-2600(16)30427-1. Epub 2016 Dec 21. Lancet Respir Med. 2017. PMID: 28011037 Clinical Trial.

96

Perceived emotion genuineness: normative ratings for popular facial expression stimuli and the development of perceived-as-genuine and perceived-as-fake sets.

Dawel A, Wright L, Irons J, Dumbleton R, Palermo R, O'Kearney R, McKone E. Dawel A, et al. Among authors: mckone e. Behav Res Methods. 2017 Aug;49(4):1539-1562. doi: 10.3758/s13428-016-0813-2. Behav Res Methods. 2017. PMID: 27928745

97

Face-blind for other-race faces: Individual differences in other-race recognition impairments.

Wan L, Crookes K, Dawel A, Pidcock M, Hall A, McKone E. Wan L, et al. Among authors: mckone e. J Exp Psychol Gen. 2017 Jan;146(1):102-122. doi: 10.1037/xge0000249. Epub 2016 Nov 28. J Exp Psychol Gen. 2017. PMID: 27893239

98

Do people have insight into their face recognition abilities?

Palermo R, Rossion B, Rhodes G, Laguesse R, Tez T, Hall B, Albonico A, Malaspina M, Daini R, Irons J, Al-Janabi S, Taylor LC, Rivolta D, McKone E. Palermo R, et al. Among authors: mckone e. Q J Exp Psychol (Hove). 2017 Feb;70(2):218-233. doi: 10.1080/17470218.2016.1161058. Epub 2016 Mar 23. Q J Exp Psychol (Hove). 2017. PMID: 26935244 Free article.

99

Relationship between pulmonary hyperinflation and dyspnoea severity during acute exacerbations of cystic fibrosis.

Nicholson TT, Barry PJ, Waterhouse DF, Nolan GM, McKone EF, Gallagher CG. Nicholson TT, et al. Respirology. 2017 Jan;22(1):141-148. doi: 10.1111/resp.12885. Epub 2016 Sep 11. Respirology. 2017. PMID: 27614791

100

Pharmacogenetics of cystic fibrosis treatment.

Carter SC, McKone EF. Carter SC, et al. Pharmacogenomics. 2016 Aug;17(13):1453-63. doi: 10.2217/pgs.16.25. Epub 2016 Aug 4. Pharmacogenomics. 2016. PMID: 27490265 Review.

101

Personalised medicine in advanced cystic fibrosis.

McKone EF. McKone EF. Lancet Respir Med. 2016 Aug;4(8):594-595. doi: 10.1016/S2213-2600(16)30156-4. Epub 2016 Jun 10. Lancet Respir Med. 2016. PMID: 27298016 No abstract available.

102

Acute administration of ivacaftor to people with cystic fibrosis and a G551D-CFTR mutation reveals smooth muscle abnormalities.

Adam RJ, Hisert KB, Dodd JD, Grogan B, Launspach JL, Barnes JK, Gallagher CG, Sieren JP, Gross TJ, Fischer AJ, Cavanaugh JE, Hoffman EA, Singh PK, Welsh MJ, McKone EF, Stoltz DA. Adam RJ, et al. Among authors: mckone ef. JCI Insight. 2016 Apr 7;1(4):e86183. doi: 10.1172/jci.insight.86183. JCI Insight. 2016. PMID: 27158673 Free PMC article.

103

Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis.

Hisert KB, Schoenfelt KQ, Cooke G, Grogan B, Launspach JL, Gallagher CG, Donnelly SC, Welsh MJ, Singh PK, McKone EF, Becker L. Hisert KB, et al. Am J Respir Cell Mol Biol. 2016 Apr;54(4):594-7. doi: 10.1165/rcmb.2015-0322LE. Am J Respir Cell Mol Biol. 2016. PMID: 27035067 Free PMC article. No abstract available.

104

Social and attention-to-detail subclusters of autistic traits differentially predict looking at eyes and face identity recognition ability.

Davis J, McKone E, Zirnsak M, Moore T, O'Kearney R, Apthorp D, Palermo R. Davis J, et al. Among authors: mckone e. Br J Psychol. 2017 Feb;108(1):191-219. doi: 10.1111/bjop.12188. Epub 2016 Mar 14. Br J Psychol. 2017. PMID: 26988108

105

A cultural setting where the other-race effect on face recognition has no social-motivational component and derives entirely from lifetime perceptual experience.

Wan L, Crookes K, Reynolds KJ, Irons JL, McKone E. Wan L, et al. Among authors: mckone e. Cognition. 2015 Nov;144:91-115. doi: 10.1016/j.cognition.2015.07.011. Epub 2015 Aug 7. Cognition. 2015. PMID: 26257000 Clinical Trial.

106

Ambient air pollution, lung function, and airway responsiveness in asthmatic children.

Ierodiakonou D, Zanobetti A, Coull BA, Melly S, Postma DS, Boezen HM, Vonk JM, Williams PV, Shapiro GG, McKone EF, Hallstrand TS, Koenig JQ, Schildcrout JS, Lumley T, Fuhlbrigge AN, Koutrakis P, Schwartz J, Weiss ST, Gold DR; Childhood Asthma Management Program Research Group. Ierodiakonou D, et al. J Allergy Clin Immunol. 2016 Feb;137(2):390-9. doi: 10.1016/j.jaci.2015.05.028. Epub 2015 Jul 14. J Allergy Clin Immunol. 2016. PMID: 26187234 Free PMC article.

107

Sustained Benefit from ivacaftor demonstrated by combining clinical trial and cystic fibrosis patient registry data.

Sawicki GS, McKone EF, Pasta DJ, Millar SJ, Wagener JS, Johnson CA, Konstan MW. Sawicki GS, et al. Am J Respir Crit Care Med. 2015 Oct 1;192(7):836-42. doi: 10.1164/rccm.201503-0578OC. Am J Respir Crit Care Med. 2015. PMID: 26132840

108

Children can discriminate the authenticity of happy but not sad or fearful facial expressions, and use an immature intensity-only strategy.

Dawel A, Palermo R, O'Kearney R, McKone E. Dawel A, et al. Among authors: mckone e. Front Psychol. 2015 May 5;6:462. doi: 10.3389/fpsyg.2015.00462. eCollection 2015. Front Psychol. 2015. PMID: 25999868 Free PMC article.

109

Tracheomalacia in Adults with Cystic Fibrosis: Determination of Prevalence and Severity with Dynamic Cine CT.

McDermott S, Barry SC, Judge EE, Collins S, de Jong PA, Tiddens HA, McKone EF, Gallagher CG, Dodd JD. McDermott S, et al. Among authors: mckone ef. Radiology. 2015 Jun;275(3):934. doi: 10.1148/radiol.2015154012. Radiology. 2015. PMID: 25997140 No abstract available.

110

Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, Ratjen F, Rowe SM, Waltz D, Boyle MP; TRAFFIC Study Group; TRANSPORT Study Group. Wainwright CE, et al. Among authors: mckone ef. N Engl J Med. 2015 Jul 16;373(3):220-31. doi: 10.1056/NEJMoa1409547. Epub 2015 May 17. N Engl J Med. 2015. PMID: 25981758 Free PMC article. Clinical Trial.

111

Elevated levels of callous unemotional traits are associated with reduced attentional cueing, with no specificity for fear or eyes.

Dawel A, McKone E, O'Kearney R, Sellbom M, Irons J, Palermo R. Dawel A, et al. Among authors: mckone e. Personal Disord. 2015 Jul;6(3):216-228. doi: 10.1037/per0000108. Epub 2015 Feb 23. Personal Disord. 2015. PMID: 25705978

112

Association of sweat chloride concentration at time of diagnosis and CFTR genotype with mortality and cystic fibrosis phenotype.

McKone EF, Velentgas P, Swenson AJ, Goss CH. McKone EF, et al. J Cyst Fibros. 2015 Sep;14(5):580-6. doi: 10.1016/j.jcf.2015.01.005. Epub 2015 Feb 3. J Cyst Fibros. 2015. PMID: 25660278 Free article.

113

Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST).

McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC; VX08-770-105 (PERSIST) Study Group. McKone EF, et al. Lancet Respir Med. 2014 Nov;2(11):902-910. doi: 10.1016/S2213-2600(14)70218-8. Epub 2014 Oct 9. Lancet Respir Med. 2014. PMID: 25311995 Clinical Trial.

114

Fearful faces drive gaze-cueing and threat bias effects in children on the lookout for danger.

Dawel A, Palermo R, O'Kearney R, Irons J, McKone E. Dawel A, et al. Among authors: mckone e. Dev Sci. 2015 Mar;18(2):219-31. doi: 10.1111/desc.12203. Epub 2014 Jul 18. Dev Sci. 2015. PMID: 25040889

115

Pulmonary blastoma: a case report and review of the literature.

Smyth RJ, Fabre A, Dodd JD, Bartosik W, Gallagher CG, McKone EF. Smyth RJ, et al. BMC Res Notes. 2014 May 13;7:294. doi: 10.1186/1756-0500-7-294. BMC Res Notes. 2014. PMID: 24885892 Free PMC article. Review.

116

Face identity aftereffects increase monotonically with adaptor extremity over, but not beyond, the range of natural faces.

McKone E, Jeffery L, Boeing A, Clifford CW, Rhodes G. McKone E, et al. Vision Res. 2014 May;98:1-13. doi: 10.1016/j.visres.2014.01.007. Epub 2014 Feb 28. Vision Res. 2014. PMID: 24582798 Free article.

117

A new theoretical approach to improving face recognition in disorders of central vision: face caricaturing.

Irons J, McKone E, Dumbleton R, Barnes N, He X, Provis J, Ivanovici C, Kwa A. Irons J, et al. Among authors: mckone e. J Vis. 2014 Feb 17;14(2):12. doi: 10.1167/14.2.12. J Vis. 2014. PMID: 24534882 Free article. Clinical Trial.

118

Ivacaftor imaging response in cystic fibrosis.

Hoare S, McEvoy S, McCarthy CJ, Kilcoyne A, Brady D, Gibney B, Gallagher CG, McKone EF, Dodd JD. Hoare S, et al. Am J Respir Crit Care Med. 2014 Feb 15;189(4):484. doi: 10.1164/rccm.201308-1433IM. Am J Respir Crit Care Med. 2014. PMID: 24528318 No abstract available.

119

Aftereffects support opponent coding of face gender.

Pond S, Kloth N, McKone E, Jeffery L, Irons J, Rhodes G. Pond S, et al. Among authors: mckone e. J Vis. 2013 Dec 20;13(14):16. doi: 10.1167/13.14.16. J Vis. 2013. PMID: 24361588 Free article.

120

Domain-specific development of face memory but not face perception.

Weigelt S, Koldewyn K, Dilks DD, Balas B, McKone E, Kanwisher N. Weigelt S, et al. Among authors: mckone e. Dev Sci. 2014 Jan;17(1):47-58. doi: 10.1111/desc.12089. Epub 2013 Oct 7. Dev Sci. 2014. PMID: 24118764

121

New tests to measure individual differences in matching and labelling facial expressions of emotion, and their association with ability to recognise vocal emotions and facial identity.

Palermo R, O'Connor KB, Davis JM, Irons J, McKone E. Palermo R, et al. Among authors: mckone e. PLoS One. 2013 Jun 28;8(6):e68126. doi: 10.1371/journal.pone.0068126. Print 2013. PLoS One. 2013. PMID: 23840821 Free PMC article.

122

Importance of the inverted control in measuring holistic face processing with the composite effect and part-whole effect.

McKone E, Davies AA, Darke H, Crookes K, Wickramariyaratne T, Zappia S, Fiorentini C, Favelle S, Broughton M, Fernando D. McKone E, et al. Front Psychol. 2013 Feb 4;4:33. doi: 10.3389/fpsyg.2013.00033. eCollection 2013. Front Psychol. 2013. PMID: 23382725 Free PMC article.

123

A robust method of measuring other-race and other-ethnicity effects: the Cambridge Face Memory Test format.

McKone E, Stokes S, Liu J, Cohan S, Fiorentini C, Pidcock M, Yovel G, Broughton M, Pelleg M. McKone E, et al. PLoS One. 2012;7(10):e47956. doi: 10.1371/journal.pone.0047956. Epub 2012 Oct 30. PLoS One. 2012. PMID: 23118912 Free PMC article.

124

Pleural effusion arising from a rare pancreatic neoplasm.

Cushen B, McKeating A, Garvey JF, Dodd JD, Mulcahy H, Geoghegan J, McKone EF, Gallagher CG. Cushen B, et al. Eur Respir J. 2012 Nov;40(5):1298-300. doi: 10.1183/09031936.00035312. Eur Respir J. 2012. PMID: 23115315 Free article. No abstract available.

125

Global face distortion aftereffects tap face-specific and shape-generic processes.

Dennett HW, Edwards M, McKone E. Dennett HW, et al. Among authors: mckone e. J Vis. 2012 Oct 17;12(11):11. doi: 10.1167/12.11.11. J Vis. 2012. PMID: 23077205 Free article.

126

Face aftereffects predict individual differences in face recognition ability.

Dennett HW, McKone E, Edwards M, Susilo T. Dennett HW, et al. Among authors: mckone e. Psychol Sci. 2012;23(11):1279-87. doi: 10.1177/0956797612446350. Epub 2012 Oct 16. Psychol Sci. 2012. PMID: 23073026

127

Not just fear and sadness: meta-analytic evidence of pervasive emotion recognition deficits for facial and vocal expressions in psychopathy.

Dawel A, O'Kearney R, McKone E, Palermo R. Dawel A, et al. Among authors: mckone e. Neurosci Biobehav Rev. 2012 Nov;36(10):2288-304. doi: 10.1016/j.neubiorev.2012.08.006. Epub 2012 Aug 27. Neurosci Biobehav Rev. 2012. PMID: 22944264 Review.

128

Molecular detection of an atypical, highly resistant, clonal Pseudomonas aeruginosa isolate in cystic fibrosis patients.

Keating D, Crowe MJ, Kennedy B, Salmon A, Britton D, Gallagher CG, McKone EF, Schaffer K. Keating D, et al. J Cyst Fibros. 2013 Mar;12(2):141-6. doi: 10.1016/j.jcf.2012.07.007. Epub 2012 Aug 16. J Cyst Fibros. 2013. PMID: 22902869 Free article.

129

A critical review of the development of face recognition: experience is less important than previously believed.

McKone E, Crookes K, Jeffery L, Dilks DD. McKone E, et al. Cogn Neuropsychol. 2012;29(1-2):174-212. doi: 10.1080/02643294.2012.660138. Epub 2012 Feb 23. Cogn Neuropsychol. 2012. PMID: 22360676 Review.

130

Individual differences in the ability to recognise facial identity are associated with social anxiety.

Davis JM, McKone E, Dennett H, O'Connor KB, O'Kearney R, Palermo R. Davis JM, et al. Among authors: mckone e. PLoS One. 2011;6(12):e28800. doi: 10.1371/journal.pone.0028800. Epub 2011 Dec 14. PLoS One. 2011. PMID: 22194916 Free PMC article.

131

Face ethnicity and measurement reliability affect face recognition performance in developmental prosopagnosia: evidence from the Cambridge Face Memory Test-Australian.

McKone E, Hall A, Pidcock M, Palermo R, Wilkinson RB, Rivolta D, Yovel G, Davis JM, O'Connor KB. McKone E, et al. Cogn Neuropsychol. 2011 Mar;28(2):109-46. doi: 10.1080/02643294.2011.616880. Cogn Neuropsychol. 2011. PMID: 22122116

132

Face recognition impairments despite normal holistic processing and face space coding: evidence from a case of developmental prosopagnosia.

Susilo T, McKone E, Dennett H, Darke H, Palermo R, Hall A, Pidcock M, Dawel A, Jeffery L, Wilson CE, Rhodes G. Susilo T, et al. Among authors: mckone e. Cogn Neuropsychol. 2010 Dec;27(8):636-64. doi: 10.1080/02643294.2011.613372. Cogn Neuropsychol. 2010. PMID: 22074472

133

The Cambridge Car Memory Test: a task matched in format to the Cambridge Face Memory Test, with norms, reliability, sex differences, dissociations from face memory, and expertise effects.

Dennett HW, McKone E, Tavashmi R, Hall A, Pidcock M, Edwards M, Duchaine B. Dennett HW, et al. Among authors: mckone e. Behav Res Methods. 2012 Jun;44(2):587-605. doi: 10.3758/s13428-011-0160-2. Behav Res Methods. 2012. PMID: 22012343

134

Distinguishing norm-based from exemplar-based coding of identity in children: evidence from face identity aftereffects.

Jeffery L, Rhodes G, McKone E, Pellicano E, Crookes K, Taylor E. Jeffery L, et al. Among authors: mckone e. J Exp Psychol Hum Percept Perform. 2011 Dec;37(6):1824-40. doi: 10.1037/a0025643. Epub 2011 Oct 3. J Exp Psychol Hum Percept Perform. 2011. PMID: 21967275

135

Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis.

Jackson AD, Daly L, Jackson AL, Kelleher C, Marshall BC, Quinton HB, Fletcher G, Harrington M, Zhou S, McKone EF, Gallagher C, Foley L, Fitzpatrick P. Jackson AD, et al. Thorax. 2011 Aug;66(8):674-9. doi: 10.1136/thoraxjnl-2011-200038. Epub 2011 Jun 8. Thorax. 2011. PMID: 21653925 Free PMC article.

136

Impaired holistic coding of facial expression and facial identity in congenital prosopagnosia.

Palermo R, Willis ML, Rivolta D, McKone E, Wilson CE, Calder AJ. Palermo R, et al. Among authors: mckone e. Neuropsychologia. 2011 Apr;49(5):1226-1235. doi: 10.1016/j.neuropsychologia.2011.02.021. Epub 2011 Feb 17. Neuropsychologia. 2011. PMID: 21333662 Free PMC article.

137

Solving the upside-down puzzle: Why do upright and inverted face aftereffects look alike?

Susilo T, McKone E, Edwards M. Susilo T, et al. Among authors: mckone e. J Vis. 2010 Nov 1;10(13):1. doi: 10.1167/10.13.1. J Vis. 2010. PMID: 21149314 Free article.

138

Development, validation, and implementation of a questionnaire assessing disease knowledge and understanding in adult cystic fibrosis patients.

Siklosi KR, Gallagher CG, McKone EF. Siklosi KR, et al. J Cyst Fibros. 2010 Dec;9(6):400-5. doi: 10.1016/j.jcf.2010.07.001. Epub 2010 Aug 14. J Cyst Fibros. 2010. PMID: 20709606 Free article.

139

Four-to-six-year-old children use norm-based coding in face-space.

Jeffery L, McKone E, Haynes R, Firth E, Pellicano E, Rhodes G. Jeffery L, et al. Among authors: mckone e. J Vis. 2010 May 1;10(5):18. doi: 10.1167/10.5.18. J Vis. 2010. PMID: 20616134 Free article.

140

Asia has the global advantage: Race and visual attention.

McKone E, Aimola Davies A, Fernando D, Aalders R, Leung H, Wickramariyaratne T, Platow MJ. McKone E, et al. Vision Res. 2010 Jul 21;50(16):1540-9. doi: 10.1016/j.visres.2010.05.010. Epub 2010 May 17. Vision Res. 2010. PMID: 20488198 Free article.

141

A strong role for nature in face recognition.

McKone E, Palermo R. McKone E, et al. Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):4795-6. doi: 10.1073/pnas.1000567107. Epub 2010 Mar 8. Proc Natl Acad Sci U S A. 2010. PMID: 20212105 Free PMC article. No abstract available.

142

Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task.

Brown J, McKone E, Ward J. Brown J, et al. Among authors: mckone e. Psychopharmacology (Berl). 2010 Mar;209(1):51-67. doi: 10.1007/s00213-009-1766-2. Epub 2010 Feb 2. Psychopharmacology (Berl). 2010. PMID: 20119830

143

What shape are the neural response functions underlying opponent coding in face space? A psychophysical investigation.

Susilo T, McKone E, Edwards M. Susilo T, et al. Among authors: mckone e. Vision Res. 2010 Feb 8;50(3):300-14. doi: 10.1016/j.visres.2009.11.016. Epub 2009 Nov 26. Vision Res. 2010. PMID: 19944116 Free article.

144

Diagnosing prosopagnosia: effects of ageing, sex, and participant-stimulus ethnic match on the Cambridge Face Memory Test and Cambridge Face Perception Test.

Bowles DC, McKone E, Dawel A, Duchaine B, Palermo R, Schmalzl L, Rivolta D, Wilson CE, Yovel G. Bowles DC, et al. Among authors: mckone e. Cogn Neuropsychol. 2009 Jul;26(5):423-55. doi: 10.1080/02643290903343149. Epub 2009 Nov 16. Cogn Neuropsychol. 2009. PMID: 19921582

145

Why does picture-plane inversion sometimes dissociate perception of features and spacing in faces, and sometimes not? Toward a new theory of holistic processing.

McKone E, Yovel G. McKone E, et al. Psychon Bull Rev. 2009 Oct;16(5):778-97. doi: 10.3758/PBR.16.5.778. Psychon Bull Rev. 2009. PMID: 19815781 Review.

146

The composite task reveals stronger holistic processing in children than adults for child faces.

Susilo T, Crookes K, McKone E, Turner H. Susilo T, et al. Among authors: mckone e. PLoS One. 2009 Jul 29;4(7):e6460. doi: 10.1371/journal.pone.0006460. PLoS One. 2009. PMID: 19641627 Free PMC article.

147

Tracheomalacia in adults with cystic fibrosis: determination of prevalence and severity with dynamic cine CT.

McDermott S, Barry SC, Judge EP, Collins S, de Jong PA, Tiddens HA, McKone EF, Gallagher CC, Dodd JD. McDermott S, et al. Radiology. 2009 Aug;252(2):577-86. doi: 10.1148/radiol.2522081956. Epub 2009 Jun 9. Radiology. 2009. PMID: 19508990

148

Early maturity of face recognition: no childhood development of holistic processing, novel face encoding, or face-space.

Crookes K, McKone E. Crookes K, et al. Among authors: mckone e. Cognition. 2009 May;111(2):219-47. doi: 10.1016/j.cognition.2009.02.004. Epub 2009 Mar 17. Cognition. 2009. PMID: 19296930

149

Blurry means good focus: myopia and visual attention.

McKone E, Aimola Davies A, Fernando D. McKone E, et al. Perception. 2008;37(11):1765-8. doi: 10.1068/p6156. Perception. 2008. PMID: 19189737

150

Holistic processing for faces operates over a wide range of sizes but is strongest at identification rather than conversational distances.

McKone E. McKone E. Vision Res. 2009 Jan;49(2):268-83. doi: 10.1016/j.visres.2008.10.020. Epub 2008 Dec 9. Vision Res. 2009. PMID: 19022276 Free article.

151

Androgens, exercise capacity, and muscle function in cystic fibrosis.

Barry PJ, Waterhouse DF, Reilly CM, McKenna TJ, McKone EF, Gallagher CG. Barry PJ, et al. Chest. 2008 Dec;134(6):1258-1264. doi: 10.1378/chest.08-1091. Epub 2008 Aug 8. Chest. 2008. PMID: 18689588

152

Configural processing and face viewpoint.

McKone E. McKone E. J Exp Psychol Hum Percept Perform. 2008 Apr;34(2):310-27. doi: 10.1037/0096-1523.34.2.310. J Exp Psychol Hum Percept Perform. 2008. PMID: 18377173

153

Understanding the developmental origins of primate face recognition: theoretical commentary on Martin-Malivel and Okada (2007).

McKone E, Crookes K. McKone E, et al. Behav Neurosci. 2007 Dec;121(6):1437-41. doi: 10.1037/0735-7044.121.6.1437. Behav Neurosci. 2007. PMID: 18085899

154

Aftereffects for face attributes with different natural variability: adapter position effects and neural models.

Robbins R, McKone E, Edwards M. Robbins R, et al. Among authors: mckone e. J Exp Psychol Hum Percept Perform. 2007 Jun;33(3):570-92. doi: 10.1037/0096-1523.33.3.570. J Exp Psychol Hum Percept Perform. 2007. PMID: 17563222

155

A long-term ecstasy-related change in visual perception.

Brown J, Edwards M, McKone E, Ward J. Brown J, et al. Among authors: mckone e. Psychopharmacology (Berl). 2007 Aug;193(3):437-46. doi: 10.1007/s00213-007-0785-0. Epub 2007 Apr 25. Psychopharmacology (Berl). 2007. PMID: 17457578 Clinical Trial.

156

Familiar other-race faces show normal holistic processing and are robust to perceptual stress.

McKone E, Brewer JL, MacPherson S, Rhodes G, Hayward WG. McKone E, et al. Perception. 2007;36(2):224-48. doi: 10.1068/p5499. Perception. 2007. PMID: 17402665 Clinical Trial.

157

Can generic expertise explain special processing for faces?

McKone E, Kanwisher N, Duchaine BC. McKone E, et al. Trends Cogn Sci. 2007 Jan;11(1):8-15. doi: 10.1016/j.tics.2006.11.002. Epub 2006 Nov 28. Trends Cogn Sci. 2007. PMID: 17129746 Review.

158

CFTR genotype as a predictor of prognosis in cystic fibrosis.

McKone EF, Goss CH, Aitken ML. McKone EF, et al. Chest. 2006 Nov;130(5):1441-7. doi: 10.1378/chest.130.5.1441. Chest. 2006. PMID: 17099022

159

The evidence rejects the expertise hypothesis: reply to Gauthier & Bukach.

McKone E, Robbins R. McKone E, et al. Cognition. 2007 May;103(2):331-6. doi: 10.1016/j.cognition.2006.05.014. Epub 2006 Jul 13. Cognition. 2007. PMID: 16842769

In Robbins, R. & McKone, E. (2006). No face-like processing for object-of-expertise in three behavioural tasks. ...

160

Memory conjunction errors for realistic faces are consistent with configural processing.

McKone E, Peh YX. McKone E, et al. Psychon Bull Rev. 2006 Feb;13(1):106-11. doi: 10.3758/bf03193820. Psychon Bull Rev. 2006. PMID: 16724776

161

Variants in the glutamate-cysteine-ligase gene are associated with cystic fibrosis lung disease.

McKone EF, Shao J, Frangolias DD, Keener CL, Shephard CA, Farin FM, Tonelli MR, Pare PD, Sandford AJ, Aitken ML, Kavanagh TJ. McKone EF, et al. Am J Respir Crit Care Med. 2006 Aug 15;174(4):415-9. doi: 10.1164/rccm.200508-1281OC. Epub 2006 May 11. Am J Respir Crit Care Med. 2006. PMID: 16690975 Free PMC article.

162

Aggressive prenatal care results in successful fetal outcomes in CF women.

Cheng EY, Goss CH, McKone EF, Galic V, Debley CK, Tonelli MR, Aitken ML. Cheng EY, et al. J Cyst Fibros. 2006 May;5(2):85-91. doi: 10.1016/j.jcf.2006.01.002. J Cyst Fibros. 2006. PMID: 16650742 Free article.

163

No face-like processing for objects-of-expertise in three behavioural tasks.

Robbins R, McKone E. Robbins R, et al. Among authors: mckone e. Cognition. 2007 Apr;103(1):34-79. doi: 10.1016/j.cognition.2006.02.008. Epub 2006 Apr 17. Cognition. 2007. PMID: 16616910

164

Sensitivity of 4-year-olds to featural and second-order relational changes in face distinctiveness.

McKone E, Boyer BL. McKone E, et al. J Exp Child Psychol. 2006 Jun;94(2):134-62. doi: 10.1016/j.jecp.2006.01.001. Epub 2006 Feb 17. J Exp Child Psychol. 2006. PMID: 16483596

165

Orientation tuning of human face processing estimated by contrast matching in transparency displays.

Martini P, McKone E, Nakayama K. Martini P, et al. Among authors: mckone e. Vision Res. 2006 Jun;46(13):2102-9. doi: 10.1016/j.visres.2005.11.014. Epub 2005 Dec 27. Vision Res. 2006. PMID: 16384592 Free article.

166

Categorical and coordinate relations in faces, or Fechner's law and face space instead?

McKone E, Aitkin A, Edwards M. McKone E, et al. J Exp Psychol Hum Percept Perform. 2005 Dec;31(6):1181-98. doi: 10.1037/0096-1523.31.6.1181. J Exp Psychol Hum Percept Perform. 2005. PMID: 16366783

167

Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis.

McKone EF, Barry SC, Fitzgerald MX, Gallagher CG. McKone EF, et al. J Appl Physiol (1985). 2005 Sep;99(3):1012-8. doi: 10.1152/japplphysiol.00475.2004. Epub 2005 Apr 28. J Appl Physiol (1985). 2005. PMID: 15860682 Free article. Clinical Trial.

168

Publications and extramural activities of general internal medicine and medicine subspecialty clinician-educators: a multicenter study.

Kempainen RR, McKone EF, Rubenfeld GD, Scott CS, Tonelli MR. Kempainen RR, et al. Acad Med. 2005 Mar;80(3):238-43. doi: 10.1097/00001888-200503000-00007. Acad Med. 2005. PMID: 15734805

169

Comparison of scholarly productivity of general and subspecialty clinician-educators in internal medicine.

Kempainen RR, McKone EF, Rubenfeld GD, Scott CS, Tonelli MR. Kempainen RR, et al. Teach Learn Med. 2004 Fall;16(4):323-8. doi: 10.1207/s15328015tlm1604_4. Teach Learn Med. 2004. PMID: 15582868

170

Adults with dyslexia show deficits on spatial frequency doubling and visual attention tasks.

Buchholz J, McKone E. Buchholz J, et al. Among authors: mckone e. Dyslexia. 2004 Feb;10(1):24-43. doi: 10.1002/dys.263. Dyslexia. 2004. PMID: 14998141

171

Isolating the special component of face recognition: peripheral identification and a Mooney face.

McKone E. McKone E. J Exp Psychol Learn Mem Cogn. 2004 Jan;30(1):181-97. doi: 10.1037/0278-7393.30.1.181. J Exp Psychol Learn Mem Cogn. 2004. PMID: 14736306

172

Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study.

McKone EF, Emerson SS, Edwards KL, Aitken ML. McKone EF, et al. Lancet. 2003 May 17;361(9370):1671-6. doi: 10.1016/S0140-6736(03)13368-5. Lancet. 2003. PMID: 12767731

173

Can holistic processing be learned for inverted faces?

Robbins R, McKone E. Robbins R, et al. Among authors: mckone e. Cognition. 2003 May;88(1):79-107. doi: 10.1016/s0010-0277(03)00020-9. Cognition. 2003. PMID: 12711154

174

Dissociations between implicit and explicit memory in children: the role of strategic processing and the knowledge base.

Murphy K, McKone E, Slee J. Murphy K, et al. Among authors: mckone e. J Exp Child Psychol. 2003 Feb;84(2):124-65. doi: 10.1016/s0022-0965(03)00002-x. J Exp Child Psychol. 2003. PMID: 12609496

175

Adrenal insufficiency and testicular failure secondary to megestrol acetate therapy in a patient with cystic fibrosis.

McKone EF, Tonelli MR, Aitken ML. McKone EF, et al. Pediatr Pulmonol. 2002 Nov;34(5):381-3. doi: 10.1002/ppul.10184. Pediatr Pulmonol. 2002. PMID: 12357484

176

Use of the gas exchange threshold to noninvasively determine the lactate threshold in patients with cystic fibrosis.

Thin AG, Linnane SJ, McKone EF, Freaney R, FitzGerald MX, Gallagher CG, McLoughlin P. Thin AG, et al. Chest. 2002 Jun;121(6):1761-70. doi: 10.1378/chest.121.6.1761. Chest. 2002. PMID: 12065336

177

In what sense is implicit memory "episodic"? The effect of reinstating environmental context.

McKone E, French B. McKone E, et al. Psychon Bull Rev. 2001 Dec;8(4):806-11. doi: 10.3758/bf03196221. Psychon Bull Rev. 2001. PMID: 11848603

178

Categorical perception of face identity in noise isolates configural processing.

McKone E, Martini P, Nakayama K. McKone E, et al. J Exp Psychol Hum Percept Perform. 2001 Jun;27(3):573-99. doi: 10.1037//0096-1523.27.3.573. J Exp Psychol Hum Percept Perform. 2001. PMID: 11424647

179

Short-term implicit memory: visual, auditory, and cross-modality priming.

McKone E, Dennis C. McKone E, et al. Psychon Bull Rev. 2000 Jun;7(2):341-6. doi: 10.3758/bf03212991. Psychon Bull Rev. 2000. PMID: 10909143

180

Orientation invariance in naming rotated objects: individual differences and repetition priming.

McKone E, Grenfell T. McKone E, et al. Percept Psychophys. 1999 Nov;61(8):1590-603. doi: 10.3758/bf03213120. Percept Psychophys. 1999. PMID: 10598472

181

Acquisition of novel traces in short-term implicit memory: priming for nonwords and new associations.

McKone E, Trynes K. McKone E, et al. Mem Cognit. 1999 Jul;27(4):619-32. doi: 10.3758/bf03211556. Mem Cognit. 1999. PMID: 10479821

182

The decay of short-term implicit memory: unpacking lag.

McKone E. McKone E. Mem Cognit. 1998 Nov;26(6):1173-86. doi: 10.3758/bf03201193. Mem Cognit. 1998. PMID: 9847544

183

Environmental policy analysis: evaluating toxic impact assessment methods: what works best.

McKone EG. McKone EG. Environ Sci Technol. 1998 Mar 1;32(5):138A-44A. doi: 10.1021/es9840403. Environ Sci Technol. 1998. PMID: 21662154

HERTWICH Energy and Resources Group University of California Berkeley, CA 94720-3050 WILLIAM S. PEASE Environmental Defense Fund Oakland, CA 95616 THOMAS E. MCKONE Environmental Health Science University of California Berkeley, CA 94720-7360....

HERTWICH Energy and Resources Group University of California Berkeley, CA 94720-3050 WILLIAM S. PEASE Environmental Defense Fund Oakland, CA …

184

Explicit contamination in "implicit" memory for new associations.

McKone E, Slee JA. McKone E, et al. Mem Cognit. 1997 May;25(3):352-66. doi: 10.3758/bf03211291. Mem Cognit. 1997. PMID: 9184487

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page